Systematic Review of the Impact of Registration and Screening on Colorectal Cancer Incidence and Mortality in Familial Adenomatous Polyposis and Lynch Syndrome | oneFAPvoice

welcome to oneFAPvoice

- a positively charged Familial Adenomatous Polyposis community.
  • join today!
scientific articles

Systematic Review of the Impact of Registration and Screening on Colorectal Cancer Incidence and Mortality in Familial Adenomatous Polyposis and Lynch Syndrome

key information

source: The British journal of surgery

year: 2013

authors: Barrow P, Khan M, Lalloo F, Evans D G, Hill J

summary/abstract:

BACKGROUND:
The British Society of Gastroenterology recommends that all familial adenomatous polyposis (FAP) and Lynch syndrome (LS) families are screened in the context of a registry. This systematic review was performed to appraise the published evidence for registration and screening in relation to colorectal cancer (CRC) incidence and mortality.

METHODS:
Five electronic databases were searched using a combination of medical subject heading terms and free-text keywords. Titles and abstracts were scrutinized by two independent reviewers. Inclusion criteria were English-language studies describing CRC incidence and/or mortality in patients with FAP or LS, with comparison of either: screened and unscreened patients, or time periods before and after establishment of the registry.

RESULTS:
Of 4668 abstracts identified, 185 full-text articles were selected; 43 studies fulfilled the inclusion criteria. No randomized clinical trial evidence was identified. For FAP, 33 of 33 studies described a significant reduction of CRC incidence and mortality with registration and screening. For LS, nine of ten studies described a reduction of CRC incidence and mortality with registration and screening. Five studies (FAP, 2; LS, 3) provided evidence for complete prevention of CRC-related deaths during surveillance. Clinical and statistical heterogeneity prevented pooling of data for meta-analysis.

CONCLUSION:
Studies consistently report that registration and screening result in a reduction of CRC incidence and mortality in patients with FAP and LS (level 2a evidence, grade B recommendation). Funding and managerial support for hereditary CRC registries should be made available.

organization: Central Manchester University Hospitals NHS Foundation Trust

DOI: 10.1002/bjs.9316

read more full text source

To improve your experience on this site we use cookies. This includes cookies essential for the basic functionalities of our website, cookies used for analytical purposes and cookies enabling us to provide personalized content. You are free to set your cookie preferences at your will.
More information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.

Close